Pathophysiology and Iron Metabolism
Iron deficiency anemia develops through progressive depletion of body iron stores. Understanding normal iron metabolism comes first. The human body contains approximately 3 to 4 grams of total iron. About 70% is incorporated into hemoglobin within red blood cells.
How Iron Enters Your Body
Iron is absorbed in the duodenum and proximal jejunum. It's transported across the intestinal epithelium by divalent metal transporter 1 (DMT1). Once absorbed, iron either becomes part of new hemoglobin or stores as ferritin in hepatocytes, macrophages, and renal tubular cells.
Your body loses approximately 1 to 2 milligrams of iron daily through feces, urine, and skin shedding. Dietary iron intake normally balances these losses.
Three Stages of Iron Deficiency
Iron deficiency develops in stages. Early recognition can prevent symptomatic anemia:
- Iron stores deplete first (low ferritin, low serum iron, elevated TIBC)
- Iron-deficient erythropoiesis develops (serum iron continues falling, red blood cells are not yet anemic)
- Iron deficiency anemia manifests (low hemoglobin levels become apparent)
Common Causes
The most common causes include:
- Chronic blood loss, especially gastrointestinal bleeding
- Inadequate dietary intake
- Malabsorption disorders like celiac disease and Crohn's disease
- Increased demand during pregnancy or childhood growth
Early detection and intervention prevent progression to symptomatic anemia. This makes iron metabolism a high-yield exam concept.
Clinical Presentation and Symptoms
Iron deficiency anemia presents with symptoms from both the anemia itself and chronic iron deficiency. Anemic symptoms result from decreased oxygen-carrying capacity. These include fatigue, dyspnea on exertion, dizziness, headaches, and palpitations.
Symptoms typically develop gradually, allowing patients to develop physiologic compensation. Increased cardiac output and enhanced oxygen extraction help the body adapt over time.
Chronic Iron Deficiency Manifestations
Iron deficiency affects tissues with high metabolic demands. These include the epithelium of the tongue, esophagus, nails, and hair. Watch for these distinctive signs:
- Glossitis: smooth, red tongue
- Angular cheilitis: cracks at mouth corners
- Koilonychia: spoon-shaped nails
- Alopecia: hair loss
Behavioral and Tissue Changes
Pagophagia (ice chewing) and pica (compulsive consumption of non-food items like clay or starch) are distinctive behavioral symptoms. Severe, chronic iron deficiency can cause dysphagia (difficulty swallowing) due to esophageal webs. This condition, called Plummer-Vinson syndrome, increases cancer risk.
In children, iron deficiency impairs cognitive development, attention, and school performance. Symptom severity correlates poorly with hemoglobin levels because chronic development allows physiologic adaptation.
Diagnostic Criteria and Laboratory Findings
Diagnosing iron deficiency anemia requires combining clinical evaluation with specific laboratory tests. A systematic approach prevents missed diagnoses and confirms the condition.
Complete Blood Count Findings
The complete blood count (CBC) reveals microcytic, hypochromic anemia. Look for:
- Low hemoglobin (less than 12 g/dL in women, less than 13.5 g/dL in men)
- Low MCV (less than 80 fL)
- Low MCH (mean corpuscular hemoglobin)
The peripheral blood smear shows small red cells with central pallor. This visual confirmation supports CBC findings.
Essential Iron Studies
Iron studies are critical for confirming iron deficiency:
- Serum ferritin below 15 ng/mL indicates depleted stores
- Serum iron is decreased
- Transferrin saturation is reduced (below 16%)
- Total iron-binding capacity (TIBC) is elevated
The soluble transferrin receptor test marks iron deficiency and is particularly useful in patients with concurrent inflammation. Ferritin rises as an acute phase reactant and may falsely appear normal.
Reticulocyte and Smear Assessment
A reticulocyte count is typically low or inappropriate for the degree of anemia. This reflects impaired bone marrow response to iron limitation. The peripheral smear may show target cells, polychromasia, and basophilic stippling depending on severity.
Finding the Underlying Cause
Once iron deficiency anemia is confirmed, identify the underlying cause through detailed history. Ask about dietary intake, menses, medications like NSAIDs, and symptoms of GI bleeding. In adults without obvious bleeding sources, further investigation including endoscopy or colonoscopy is warranted. This prevents missing malignancy or other significant gastrointestinal pathology.
Treatment Strategies and Management
Treatment of iron deficiency anemia focuses on iron replacement therapy and addressing underlying causes. A two-pronged approach prevents recurrence and restores health.
Oral Iron Supplementation
Oral iron supplementation is first-line therapy. Common formulations include:
- Ferrous sulfate (most commonly prescribed due to cost and efficacy)
- Ferrous gluconate
- Ferrous fumarate
Administer 150 to 200 milligrams of elemental iron daily. Ferrous formulations are preferred over ferric forms due to superior absorption. Iron is best absorbed in acidic conditions, so taking supplements on an empty stomach enhances absorption.
Gastrointestinal side effects like nausea, constipation, and abdominal discomfort often occur. These can be reduced by taking iron with food or reducing dose, though this slows repletion.
Monitoring Treatment Response
Monitor treatment response through serial hemoglobin measurements at 2 to 4 week intervals. Hemoglobin should increase approximately 2 g/dL monthly with adequate supplementation. Patients should show increased reticulocyte count within days, indicating bone marrow response.
Therapy should continue for 3 to 6 months after hemoglobin normalization. This replenishes iron stores, as evidenced by ferritin levels above 50 ng/mL.
Intravenous Iron Therapy
Intravenous iron is reserved for specific situations:
- Malabsorption disorders
- Intolerance to oral iron
- Chronic kidney disease requiring ESA therapy
- Need for rapid iron repletion
IV formulations include iron sucrose, iron gluconate, and ferric carboxymaltose. Each has different infusion protocols and risk profiles. Parenteral iron carries small risks of anaphylaxis and iron overload but achieves faster repletion.
Treating Root Causes
Concurrent treatment of underlying causes is paramount. Provide dietary counseling, treat celiac disease or other absorption disorders, discontinue NSAIDs, or manage abnormal bleeding patterns. Without addressing root causes, iron deficiency will recur after treatment cessation.
Differential Diagnosis and Related Conditions
Iron deficiency anemia must be distinguished from other causes of microcytic anemia. This is a crucial differential diagnosis skill. The three major causes of microcytic anemia are iron deficiency anemia, thalassemia trait, and anemia of chronic disease.
Thalassemia Trait
Thalassemia trait presents with low MCV and normal or elevated ferritin. These patients have hereditary defects in globin chain synthesis rather than iron deficiency. The Mentzer index (MCV divided by RBC count) helps distinguish these conditions. Values below 13 suggest thalassemia, while values above 13 suggest iron deficiency.
Anemia of Chronic Disease
Anemia of chronic disease occurs in infections, malignancy, and inflammatory conditions. The key distinguishing feature is low iron levels AND low TIBC. This differs from iron deficiency, which has elevated TIBC. Additional findings include elevated ferritin and low soluble transferrin receptor.
Other Microcytic Conditions
Sideroblastic anemia involves mitochondrial dysfunction in porphyrin synthesis. It shows microcytic anemia but with elevated ferritin and reticulocytosis. Lead poisoning causes microcytic anemia with basophilic stippling on blood smear and elevated lead levels.
Vitamin B12 deficiency and folate deficiency typically cause macrocytic anemia. Combined deficiencies can present with normal MCV. Copper deficiency, though rare, causes microcytic anemia similar to iron deficiency but is associated with myelopathy and myelodysplasia.
Diagnostic Approach
Iron studies (ferritin, TIBC, serum iron, transferrin saturation) are pathognomonic for iron deficiency. Clinical context and additional testing differentiate other conditions. This differential diagnostic approach is heavily emphasized in medical education and board examinations.
